WuXi Healthcare Ventures

A cross-border venture capital firm focused on life sciences and healthcare.

Venture Capital Active Cambridge, United States Est. 2011
Last updated 2026-07-20
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
0
Rounds' value
$30.0M
total disclosed, rounds participated
Stages

About

WuXi Healthcare Ventures was a corporate venture arm of WuXi PharmaTech (now WuXi AppTec), headquartered in Cambridge, Massachusetts, with an additional office in Shanghai, China. The firm focused on cross-border opportunities in life sciences, with a strategy to "find in U.S. and build in China." They invested in life science, therapeutic, platform technology, and diagnostic companies, emphasizing both China and the United States. In May 2017, WuXi Healthcare Ventures merged with Frontline BioVentures to form 6 Dimensions Capital.

Portfolio · 1

Investment activity

1 portfolio exit on record.

Portfolio by sector

Health Tech & Life Sciences2

Q&A

What is WuXi Healthcare Ventures' primary investment focus?
WuXi Healthcare Ventures primarily focuses on the Health Tech & Life Sciences sector, with all of its portfolio companies and exits falling within this area.
Can you name some of WuXi Healthcare Ventures' notable portfolio companies?
WuXi Healthcare Ventures' portfolio includes Nutrinia, which focuses on neonatal gastrointestinal treatment, and WISDO HEALTH, a social health platform.
Has WuXi Healthcare Ventures had any recent exits?
Yes, WISDO HEALTH, a social health platform, was acquired by Talkspace in October 2025.
What is the typical investment range for WuXi Healthcare Ventures?
WuXi Healthcare Ventures typically invests in the range of $6M to $30M.
What funding stages does WuXi Healthcare Ventures typically participate in?
WuXi Healthcare Ventures has participated in both A Round and D Round funding stages.
When did WuXi Healthcare Ventures make its most recent portfolio investment?
WuXi Healthcare Ventures made its most recent portfolio investment in January 2020.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Founded2011

Acquisitions & public offerings

Acquired by 6 Dimensions Capital (merger with Frontline BioVentures) 2017-05